{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/vertigo/management/peripheral-vertigo/","result":{"pageContext":{"chapter":{"id":"fd3025fe-2a3b-5653-ae93-d9e6f65503c3","slug":"peripheral-vertigo","fullItemName":"Scenario: Peripheral vertigo","depth":2,"htmlHeader":"<!-- begin field 6d4ef61a-06c1-4cd3-b741-78b43b04c625 --><h2>Scenario: Peripheral vertigo</h2><!-- end field 6d4ef61a-06c1-4cd3-b741-78b43b04c625 -->","summary":"Covers the primary care management of a person with suspected peripheral vertigo and includes red flags for referral; links to topics on benign paroxysmal positional vertigo, Meniere's disease, and vestibular neuronitis for management information; management if the cause is unknown; and symptomatic drug treatment.","htmlStringContent":"<!-- begin item f04b5fd3-833a-4b3c-ab2a-5e4b01e39651 --><!-- begin field e0b7be5d-ddb3-4ad1-af20-acbc01577590 --><p>From age 18 years onwards.</p><!-- end field e0b7be5d-ddb3-4ad1-af20-acbc01577590 --><!-- end item f04b5fd3-833a-4b3c-ab2a-5e4b01e39651 -->","topic":{"id":"b94ca2c5-94f9-5b0b-8947-d7ed33aa5095","topicId":"d75cb8e1-a405-4add-9416-f4ddd4be71a4","topicName":"Vertigo","slug":"vertigo","lastRevised":"Last revised in November 2020","chapters":[{"id":"7cfbf245-8080-5408-b5af-46e6b015eaac","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"eb7fafc8-c3da-5207-80f3-b71728b95977","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"1a3b8a24-9e4d-5ef6-8305-9df3b1c317f2","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"a6c0480e-9ea3-560b-9ef9-010e2b6d6bc3","slug":"changes","fullItemName":"Changes"},{"id":"1d87a170-6a07-5578-be1a-88233309a577","slug":"update","fullItemName":"Update"}]},{"id":"3b505c43-ded3-5313-b4a7-fe0a2d033ba5","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"53494a81-9a2a-5d95-bf7d-e77e711c0574","slug":"goals","fullItemName":"Goals"},{"id":"e1f01a8c-4094-553b-a76c-f2dd90a51b2f","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"1cfd513c-3d5a-54aa-9602-3e6d3be38cba","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"25093d8c-33f4-5be7-9754-8089a9704300","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"969ceb1b-e8dd-5bee-8648-365304bee682","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"568bc797-4e2c-59a2-b4f8-b797d90d60b1","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3f307c6b-3ea3-5ffd-8491-82b6cc0395f9","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"afc89990-521e-5fdd-ae17-ac351fe1d354","slug":"definition","fullItemName":"Definition"},{"id":"17376a5d-724c-5d04-a438-253fe0405224","slug":"causes","fullItemName":"Causes"},{"id":"d4691641-4de6-57f1-a02a-a9d5537caa0d","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a5e55fa5-72d9-5ff4-923d-151c33d24a62","slug":"complications","fullItemName":"Complications"},{"id":"8264cee3-d774-5e04-a336-cbfe45355b60","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"375a4e7f-7fd0-5036-a3cc-6a0679c13bfa","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"ac52451f-5469-5c2c-8dee-9d89ff20b1fb","slug":"confirming-vertigo","fullItemName":"Confirming vertigo"},{"id":"c5647bfa-8ae2-597f-b367-8710ae469632","slug":"assessment","fullItemName":"Assessment"},{"id":"32b446b7-58ea-516a-9ba6-89e9bd5dfd13","slug":"determining-the-cause","fullItemName":"Determining the cause"}]},{"id":"47662437-22e1-5dc4-889b-55ff8cffa7c9","fullItemName":"Management","slug":"management","subChapters":[{"id":"c7179f67-2fd1-5f8f-8486-60029021ba78","slug":"central-vertigo","fullItemName":"Scenario: Central vertigo"},{"id":"fd3025fe-2a3b-5653-ae93-d9e6f65503c3","slug":"peripheral-vertigo","fullItemName":"Scenario: Peripheral vertigo"}]},{"id":"2947932c-9f33-58ca-8926-c2a8a66f953c","fullItemName":"Prescribing information","slug":"prescribing-information","subChapters":[{"id":"edb82728-4773-5ae4-81a1-a8069cbef357","slug":"cinnarizine","fullItemName":"Cinnarizine"},{"id":"0d4b2274-af67-500e-a840-fcd41623b09e","slug":"cyclizine","fullItemName":"Cyclizine"},{"id":"981f2355-58ab-5b91-b56a-649ae876203f","slug":"prochlorperazine","fullItemName":"Prochlorperazine"},{"id":"edf7a80f-dfc3-5b9c-a678-82dd7acddfbb","slug":"promethazine-teoclate","fullItemName":"Promethazine teoclate"}]},{"id":"2b7a5cd7-2c2c-5be4-89b5-e3146e3c36e6","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"3832ba17-fb19-511b-b3de-fc89bc2a3346","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"2bdd9780-7f08-58bd-bd56-e5043164ffdc","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"b8bb4197-e5b5-5db7-876b-584f0ac43071","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"d2c7a7b5-0d16-58aa-926f-96fa0fae0f86","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f217b9f5-f617-534d-bfb1-86ca071d3288","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"614e67fc-1003-5f73-90ed-fcc6fa8adc67","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"a11a0d07-8592-5c4c-89c6-b318893454cd","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"47662437-22e1-5dc4-889b-55ff8cffa7c9","slug":"management","fullItemName":"Management"},"subChapters":[{"id":"e91922c8-8143-5568-8f43-7e16f0c939a4","slug":"management-of-peripheral-vertigo","fullItemName":"Management of peripheral vertigo","depth":3,"htmlHeader":"<!-- begin field 116b41b1-dcc4-4fbf-9109-713b8dbbd9e4 --><h3>How should I manage a person with peripheral vertigo?</h3><!-- end field 116b41b1-dcc4-4fbf-9109-713b8dbbd9e4 -->","summary":null,"htmlStringContent":"<!-- begin item fbf4ab27-bab4-49dd-8979-b3ca3071fc04 --><!-- begin field d9d6b0d5-d618-4e36-8fef-c4ba60c63f2f --><ul><li><strong>Assess the person's symptoms, medical history, and clinical findings.</strong> If the person has features suggestive of a particular cause of peripheral vertigo, manage appropriately. For more information, see the relevant CKS topics on <a class=\"topic-reference external-reference\" href=\"/topics/benign-paroxysmal-positional-vertigo/\">Benign paroxysmal positional vertigo</a>, <a class=\"topic-reference external-reference\" href=\"/topics/menieres-disease/\">Meniere&#39;s disease</a>, and <a class=\"topic-reference external-reference\" href=\"/topics/vestibular-neuronitis/\">Vestibular neuronitis</a>.</li><li><strong>If a peripheral cause of vertigo is being considered,</strong> admit to hospital or urgently refer (using clinical judgement depending on type and severity of symptoms) to an appropriate specialist (depending on local service provision) if the person has:<ul><li><strong>Severe nausea and vomiting </strong>and is unable to tolerate oral fluids or symptomatic drug treatment. </li><li><strong>Very sudden onset of vertigo (within seconds) that is not provoked by positional change and is persistent.</strong></li><li><a class=\"topic-reference internal-reference\" href=\"/topics/vertigo/diagnosis/determining-the-cause/\">Central&nbsp;</a><strong>neurological symptoms or signs </strong>(for example new type of headache [especially occipital], gait disturbance, truncal ataxia, vertical nystagmus).</li><li><strong>Acute deafness without other typical features of Meniere's disease</strong>.</li></ul></li><li><strong>For all other people with vertigo of undetermined cause </strong>— refer to a balance specialist (ear, nose, and throat specialist, audiovestibular physician, neurologist, or care of the elderly physician with a special interest — depending on local service provision). The urgency of referral will depend on the person's symptoms, clinical findings, and clinical judgement.</li><li><strong>While awaiting referral, consider offering symptomatic drug treatment </strong>with prochlorperazine, or cinnarizine, cyclizine, or promethazine teoclate (antihistamines) for no longer than 1 week. <ul><li><strong>To <em>rapidly </em>relieve severe nausea or vomiting associated with vertigo, </strong>consider giving buccal prochlorperazine, or a deep intramuscular injection of prochlorperazine or cyclizine. </li><li><strong>To alleviate less severe nausea, vomiting, and vertigo, </strong>consider prescribing a short oral course of prochlorperazine, or cinnarizine, cyclizine, or promethazine teoclate (antihistamines).</li></ul></li><li><strong>If the person's symptoms deteriorate,</strong> seek specialist advice.</li></ul><!-- end field d9d6b0d5-d618-4e36-8fef-c4ba60c63f2f --><!-- end item fbf4ab27-bab4-49dd-8979-b3ca3071fc04 -->","subChapters":[{"id":"821b4161-9173-56e4-b953-fa9e13978191","slug":"basis-for-recommendation-9c9","fullItemName":"Basis for recommendation","depth":4,"htmlHeader":"<!-- begin field b5ccf051-40f7-4335-a9a0-f1958d76e023 --><h4>Basis for recommendation</h4><!-- end field b5ccf051-40f7-4335-a9a0-f1958d76e023 -->","summary":null,"htmlStringContent":"<!-- begin item 9c989842-f7fc-4313-912e-6cc135ff6f18 --><!-- begin field 177677e1-cc06-4eff-b2a8-f5687f77cf3c --><h5>Assess symptoms, medical history and clinical findings</h5><ul><li>This recommendation reflects the general approach to the diagnosis of the cause of vertigo in primary care as outlined by expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Dommaraju and Perera, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Brandt and Dieterich, 2017</a>]. </li></ul><h5>Admission and urgent referral</h5><ul><li>The recommendation on arranging admission for a person unable to tolerate oral fluids or symptomatic drug treatment is pragmatic, based on what CKS considers to be good clinical practice.</li><li>The recommendations on sudden onset of vertigo, central symptoms or signs, and acute deafness are based on expert opinion from review articles on the diagnosis of vertigo in general practice [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Kuo et al, 2008</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Barraclough and Bronstein, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Dommaraju and Perera, 2016</a>], and red flag features for urgent referral for people with acute vertigo: <ul><li>Hyperacute onset of symptoms reaching maximum intensity in several minutes, neurological symptoms and signs, purely vertical or torsional nystagmus, acute unilateral deafness, and new headache are 'red flags', indicative of a brainstem stroke or other central cause [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Barraclough and Bronstein, 2009</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Kaski and Bronstein, 2012</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Harcourt et al, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Wipperman, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Venhovens et al, 2016</a>].  </li></ul></li></ul><h5>Referral for people with vertigo of undetermined cause</h5><ul><li>The recommendation to refer people for whom vertigo has an undetermined cause is based on expert opinion in a review article on an approach to vertigo in general practice in which referral is recommended if the diagnosis is not clear [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Dommaraju and Perera, 2016</a>].  CKS recommends using clinical judgement regarding whom, and with what urgency, to refer, based on what it considers to be good clinical practice. </li></ul><h5>Symptomatic drug treatment</h5><ul><li>CKS found no good quality evidence of benefit for the different symptomatic treatment options. However, these drugs are all licensed for use in people with labyrinthine disorders, and for nausea, vomiting, and vertigo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">ABPI Medicines Compendium, 2015a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">ABPI Medicines Compendium, 2017a</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">ABPI Medicines Compendium, 2017b</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">MHRA, 2017</a>]. </li><li>Benzodiazepines are not recommended because although some experts advocate their use, CKS found no evidence to support this and they are not licensed for treating nausea, vomiting, or vertigo [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">BNF 74, 2017</a>]. They also have the potential for dependence [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Dommaraju and Perera, 2016</a>]. </li><li>Expert opinion in review articles suggests that symptomatic drug treatment should only be used in the short term, because prolonged use may delay vestibular compensation for peripheral vertigo in conditions such as vestibular neuronitis [<a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Bronstein and Lempert, 2010</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">Wipperman, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/vertigo/references/\">van Vugt et al, 2017</a>]. </li></ul><h5>Seek specialist advice if symptoms deteriorate</h5><ul><li>This recommendation is pragmatic and is based on what CKS considers to be good medical practice. </li></ul><!-- end field 177677e1-cc06-4eff-b2a8-f5687f77cf3c --><!-- end item 9c989842-f7fc-4313-912e-6cc135ff6f18 -->","subChapters":[]}]}]}}},"staticQueryHashes":["3666801979"]}